Abiopharma

New Form 3 - HYPERION DEFI, INC. Filed: 2026-01-12 AccNo: 0001104659-26-002857 Size: 9 KB

Anand Bhaskar 🟢 acquired 30.0K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $18.83 Transaction Date: Jan 08, 2026 | Filing ID: 000003

Kavuru Vimal 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000969

Kottayil George 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000968

NEUGEBOREN EDWARD 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000967

DAVIS A BRIAN 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000966

(90% Positive) Atara Biotherapeutics Inc (ATRA) Announces Clinical Development Update

Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™

Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners

📋 Gut Robert (Director) plans to sell 26K shares of uniQure N.V. (at $26.42 each, total $677K) Filed: Jan 12, 2026 | ID: 000009

Best Frame TV: Top Picks for Your Home in 2026

Best Free Reverse Phone Lookup Services for 2026

(70% Positive) 10X Genomics Inc (TXG) Reports Q1 2026 Financial Results

New Form 424B3 - Mitesco, Inc. Filed: 2026-01-12 AccNo: 0001185185-26-000110 Size: 1 MB

La Francia espande laccesso nazionale allAAC per botensilimab + balstilimab di Agenus per il carcinoma ovarico e i sarcomi dei tessuti molli